Grifols Therapeutics, Inc.
Grifols Therapeutics, Inc., a leading global biotechnology company, is headquartered in the United States and operates extensively across Europe, Latin America, and Asia. Founded in 1909, Grifols has established itself in the biopharmaceutical industry, specialising in the development of innovative therapies derived from human plasma.
The company’s core products include immunoglobulins, albumin, and clotting factors, which are essential for treating various medical conditions, including immune deficiencies and bleeding disorders. Grifols is renowned for its commitment to quality and safety, setting industry standards with its advanced manufacturing processes.
With a strong market position, Grifols has achieved significant milestones, including the expansion of its global network of plasma collection centres. This strategic growth enhances its ability to deliver life-saving therapies to patients worldwide, solidifying its reputation as a trusted leader in the biopharmaceutical sector.
+29 vs industry average
Grifols Therapeutics, Inc.’s score of 67 is higher than 80% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Grifols Therapeutics, Inc.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has reduced its overall emissions by 19% since 0
Reported emissions
No reported emissions data is available for Grifols Therapeutics, Inc. yet.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Grifols Therapeutics, Inc.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Grifols Therapeutics, Inc. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives

Science Based Targets Initiative
Inherited from Grifols, S.A.
Carbon Disclosure Project
Inherited from Grifols, S.A.The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project